Makrocare Clinical Research Limited, a active public limited company, was established on 10 January 2008 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232TG2008PLC057098. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹6.65 Cr.
It upholds a compliant status. Employing 56 professional, Its leadership includes Vishnumurty Nidadavolu (Director), Mahesh Malneedi (Additional Director), Kanaka Malneedi Durga (Director). Past directors included Subba Rao Malneedi. It holds ₹1.01 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.1-65/2/256, Makro Towers , Kavuri Hills, Madhapur, Hyderabad, Telangana, 500033.
U24232TG2008PLC057098
057098
10 January 2008
₹7.50 Cr
₹6.65 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Makrocare Clinical Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishnumurty Nidadavolu | Director | 10 Jan 2008 | Current |
| Mahesh Malneedi | Additional Director | 01 Jul 2024 | Current |
| Kanaka Malneedi Durga | Director | 10 Jan 2008 | Current |
| Sreevalli Nidadavolu | Director | 19 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 07 Jul 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Makrocare Clinical Research Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Makrocare Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,100,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 2024 | Others | ₹1.01 Cr | Open |
Explore comprehensive loan charge details -
Makrocare Clinical Research has a workforce of 56 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Makrocare Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makrocare Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Makrocare Clinical Research Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 1.01 Cr with Charge ID 100985280 was registered on 17 Aug 2024. was documented.
Progress on Mahesh Malneedi was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2024 & has been associated with this company since 1 year 5 months . was documented.
Makrocare Clinical Research Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Sreevalli Nidadavolu was appointed as a Director was appointed as a Director on 19 Mar 2009 & has been associated with this company since 16 years 9 months . was recorded as a recent event.
Vishnumurty Nidadavolu was appointed as a Director was appointed as a Director on 10 Jan 2008 & has been associated with this company since 17 years 11 months . was recorded as a recent event.
The CIN of Makrocare Clinical Research Limited is U24232TG2008PLC057098.
Makrocare Clinical Research Limited is headquartered at H.No.1-65/2/256, Makro Towers , Kavuri Hills, Madhapur, Hyderabad, Telangana, 500033.
Makrocare Clinical Research Limited was incorporated on 10 January 2008.
The current directors of Makrocare Clinical Research Limited are
The primary industry of Makrocare Clinical Research Limited is Professional, Scientific And Technical.
Makrocare Clinical Research Limited is unlisted.
The authorized capital of Makrocare Clinical Research Limited is ₹7.50 Cr, and the paid-up capital is ₹6.65 Cr.
The compliance status of Makrocare Clinical Research Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX